Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency

Diabetes

Volumn 60, Issue 10, 2011, Pages 2496-2505

  Lisi, Simonetta ^a,b   Gamucci, Olimpia ^b   Vottari, Teresa ^a,b   Scabia, Gaia ^a,b   Funicello, Marcella ^a,b   Marchi, Matilde ^a,b   Galli, Giulia ^b   Arisi, Ivan ^c   Brandi, Rossella ^c   D'Onofrio, Mara ^c   Pinchera, Aldo ^b   Santini, Ferruccio ^b   Maffei, Margherita ^a,b  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; HAPTOGLOBIN; INSULIN; LEPTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FATTY LIVER; FOOD INTAKE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE HOMEOSTASIS IMPAIRMENT; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; LIVER; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ANIMALS; BLOOD GLUCOSE; FATTY LIVER; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; HAPTOGLOBINS; HOMEOSTASIS; INSULIN RESISTANCE; LIVER; MICE; MICE, KNOCKOUT; OBESITY;

EID: 80053428297     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1536     Document Type: Article

References (47)

1. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-985 (Pubitemid 23095272)
2. Maffei M, Funicello M, Vottari T, et al. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol 2009;7:87
3. McCormick DJ, Atassi MZ. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem 1990;9:735-742
4. Chiellini C, Bertacca A, Novelli SE, et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J Cell Physiol 2002;190:251-258 (Pubitemid 34027827)
5. Chiellini C, Santini F, Marsili A, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 2004;89:2678-2683 (Pubitemid 38766349)
6. do Nascimento CO, Hunter L, Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARgamma. Biochem Biophys Res Commun 2004;313:702-708 (Pubitemid 38021886)
7. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282 (Pubitemid 38535056)
8. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949 (Pubitemid 40712793)
9. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-152 (Pubitemid 39071617)
10. Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005;307:373-375 (Pubitemid 40139971)
11. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505
12. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124 (Pubitemid 43121796)
13. Lim SK, Kim H, Lim SK, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998;92:1870-1877 (Pubitemid 28446675)
14. Funicello M, Novelli M, Ragni M, et al. Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PLoS ONE 2007;2:e683
15. Maiuri T, Ho J, Stambolic V. Regulation of adipocyte differentiation by distinct subcellular pools of protein kinase B (PKB/Akt). J Biol Chem 2010;285:15038-15047
16. Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol 2006;411:134-193
17. Nguyen KT, Tajmir P, Lin CH, et al. Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol 2006;26:4511-4518 (Pubitemid 43877571)
18. Bensi G, Raugei G, Klefenz H, Cortese R. Structure and expression of the human haptoglobin locus. EMBO J 1985;4:119-126
19. Cinti S, Frederich RC, Zingaretti MC, De Matteis R, Flier JS, Lowell BB. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 1997;138:797-804 (Pubitemid 27110934)
20. Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr 2000;71:438-442 (Pubitemid 30061220)
21. Harada K, Shen WJ, Patel S, et al. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am J Physiol Endocrinol Metab 2003;285:E1182-E1195 (Pubitemid 37464368)
22. van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord 1995;19(Suppl. 3):S27-S36
23. Lindén D, William-Olsson L, Rhedin M, Asztély AK, Clapham JC, Schreyer S. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J Lipid Res 2004;45:1279-1288 (Pubitemid 38802631)
24. Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345-32353 (Pubitemid 39014687)
25. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 2004;432:1027-1032 (Pubitemid 40052233)
26. Wang M, Chen M, Zheng G, et al. Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice. Am J Physiol Gastrointest Liver Physiol 2008;295:G357-G366
27. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953 (Pubitemid 32756433)
28. Ryan AS, Berman DM, Nicklas BJ, et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26:2383-2388 (Pubitemid 36993330)
29. Winzer C, Wagner O, Festa A, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004;27:1721-1727 (Pubitemid 38857450)
30. Fukushima J, Kamada Y, Matsumoto H, et al. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatol Res 2009;39:724-738
31. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 2010;90:1165-1194
32. Yin XM, Ding WX. Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr Mol Med 2003;3:491-508
33. Duval C, Thissen U, Keshtkar S, et al. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes 2010;59:3181-3191. Epub 2010 Sep 21.
34. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab 2009;35:251-260
35. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50:957-969
36. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56:1960-1968 (Pubitemid 47195815)
37. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487-493 (Pubitemid 19067175)
38. Inouye KE, Shi H, Howard JK, et al. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 2007;56:2242-2250 (Pubitemid 47358231)
39. Di Gregorio GB, Yao-Borengasser A, Rasouli N, et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005;54:2305-2313 (Pubitemid 41134256)
40. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355 (Pubitemid 41532523)
41. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab 2010;95:1544-1554
42. Larter CZ, Yeh MM, van Rooyen DM, et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol 2009;24:1658-1668
43. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91-100 (Pubitemid 38056380)
44. Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003;301:1045-1050 (Pubitemid 36279218)
45. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971
46. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53(Suppl. 1):S143-S151 (Pubitemid 38168707)
47. Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099 (Pubitemid 33643677)